OEM Trademarks On Reprocessed Devices Do Not Mislead Hospitals - AMDR
This article was originally published in The Gray Sheet
Executive Summary
FDA should not require the removal of OEM trademarks and names from reprocessed devices because it would be inconsistent with the Kansas District Court's finding in U.S. Surgical Corp. v. Orris, Inc., according to the Association of Medical Device Reprocessors.
You may also be interested in...
CDRH Must Clarify Labeling Rules For Reprocessors - ADDM Citizen Petition
FDA should require reprocessors of single use devices to demonstrate prior to 510(k) clearance that a reused device will not bear an OEM trademark, the Association of Disposable Device Manufacturers asserts in a citizen petition to the agency.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.